Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine (Q34071112)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine |
scientific article |
Statements
Efficacy and safety of 1-month postpartum zidovudine-didanosine to prevent HIV-resistance mutations after intrapartum single-dose nevirapine (English)
Tim R Cressey
Narong Winiyakul
Suporn Koetsawang
Jittapol Hemvuttiphan
Prapan Sabsanong
Tapnarong Jarupanich
Nantasak Chotivanich
Prateung Liampongsabuddhi
Jullapong Achalapong
Annop Kanjanasing
Patrinee Traisaithit
Thammanoon Sukhumanant
Surabon Ariyadej
Janyaporn Ratanakosol
Karun Kengsakul
Wiroj Wannapira
Veerachai Sittipiyasakul
Witaya Pornkitprasarn
Kenneth McIntosh
Russell B Van Dyke
Sophie Le Coeur
Siripon Kanchana
PHPT-4 Study Team
1 reference
1 reference